Mainstay Medical

Irish VC group Fountain Healthcare Partners raises €118m

Group beats €100m target and intends to invest the bulk of the fund in Europe and US

Shares crash as Mainstay back pain device fails clinical trial

Company insists other data support case for its implanted electrical stimulation device

Mainstay on track to announce trial results as revenues rise

Company awaits data as it looks to roll-out ReActive8 device to patients in the US

Irish tech firms see VC funding fall for first time since 2011

Call for Government action after funding falls 9% to €453m in first six months of 2018

Mainstay Medical appoints new chief financial officer

Matthew Onaitis joins medical device company from Cidara Therapeutics

Mainstay Medical hits milestone in key US clinical trial

Group completes back pain neurostimulator implants in all 204 patients enrolled in test for device

Mainstay hits delay in Australian approval for ReActiv8

Company will wait until end of US trial on back pain therapy for new clinical data requested by authorities

Mainstay Medical raises €30m from new share placing

Company says five centres in Germany and Ireland have implanted patients with ReActiv8

Mainstay Medical passes ‘important milestone’ in clinical trials

Firm aims to bring its new therapy for chronic lower back pain to key US market

Mainstay Medical losses increase by 50%

Irish company positive about clinical trial stemming from its ReActiv8-B product

Mainstay Medical to seek further funding as full-year losses mount

Dublin-listed medical devices firm recently made its first commercial sale in Germany

The major business events happening this week

For Your Diary: INM results, UK retail figures and Girls in Tech conference

Mainstay Medical sells its first ReActiv8 implant for back pain

Iseq-listed medical device firm targets commercial growth and completion of US clinical trials

Mainstay Medical seeks approval to sell ReActiv8 in Australia

Dublin-listed firm pushes ahead with plans to commercialise back pain treatment

Irish tech firms raise €734m in first nine months of 2016

Survey shows level of investment in Irish tech companies has risen sharply in recent years

Mainstay Medical adds eighth US patent to its IP portfolio

Company’s flagship product ReActiv8 won European approval earlier this year

Most Read

1

Metro linking Dublin Airport to city centre estimated to cost €9.5bn

2

Love Island: Jack Keating needs a better gimmick than being Ronan’s son

3

AIB shows you don’t need to go to Saudi Arabia to see sportswashing in action

4

Mannix Flynn says plan to turn former Magdalene laundry into national memorial ‘disgusting’

5

Six killed in shooting at July 4th parade near Chicago

You may also like...

The Irish Times ePaper